Australian study casts doubt on sepsis guidelines
World Health Matters – Australia- by Gary Finnegan: New research suggests treatment in Australia and New Zealand for patients with sepsis is the best in the world but… read more.
World Health Matters – Australia- by Gary Finnegan: New research suggests treatment in Australia and New Zealand for patients with sepsis is the best in the world but… read more.
by Bruce Sylvester – Microvascular complications of diabetes that can lead to blindness and amputations might be reduced by statin therapy, researchers reported on Sept.9, 2014 in The Lancet… read more.
Ger Walpole, CNS (Clinical Nurse Specialist), H.Dip Oncology Nursing, BNS(Hons), Sligo Regional Hospital, Sligo. Dr Andrew Hodgson, MB, BS, BSc (Hons), FRCPI, FFPath, FRCPath. Written by Karen Mas-Mollinedo… read more.
by Thomas R. Collins – After evaluating data on 5 million adults in the UK, researchers concluded that an increasing body mass index (BMI) raises the odds of… read more.
By Vincent H Karam et al, Hôpital Paul Brousse, Villejuif, France. Liver transplantation is associated with consistent improvements in quality of life in the first three years after… read more.
Report from the Joint International Congress of ILTS, ELITA and LICAGE 2014. Recurrence of hepatitis C virus (HCV) infection after transplantation is a major challenge for centres all… read more.
by Professor John O’Grady, Kings College Hospital, London – Liver transplantation is highly successful from the technical perspective, returning the majority of patients to a level of health… read more.
by Esther Drain – Skin cancer is now the commonest cancer in the UK and the incidence is rising, mainly due to people taking more holidays in sunny… read more.
A bihormonal “artificial pancreas” improved glycemic control and led to less hypoglycemia in type 1 diabetes patients, researchers reported here.
People with diabetes have about double the risk of premature death as people of the same age without diabetes. Studies also have shown that they have about twice… read more.
by Bruce Sylvester – Metformin therapy at 500 twice daily (BID) is not protective against heart failure in non-diabetic patients following a heart attack, researchers reported on March… read more.
Analysis could eventually lead to improved therapy, researcher says. So many variables can contribute to shortness of breath that no person can keep them all straight. But a… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.